MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

10.69 +0.05 (+0.47%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care ↗
Johnson & Johnson will split its consumer health unit into a publicly traded company. 
Via Investor's Business Daily
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Unusual Options Activity Insight: Viatris ↗
On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
Earnings Scheduled For November 8, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
News headline image
Could Viatris Stock Help You Retire a Millionaire? ↗
It depends on how much help you're looking for. 
Via The Motley Fool
Topics Retirement
News headline image
3 No-Brainer Biotech Stocks to Buy Right Now ↗
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run. 
Via The Motley Fool
News headline image
2 Ultra-Cheap Stocks Trading Below Their Book Values ↗
And these stocks also pay relatively high dividends. 
Via The Motley Fool
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Why Are Theravance Bio Shares Plummeting Premarket Today? ↗
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November... 
Via Benzinga
News headline image
Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar ↗
It's kind of a boring stock. But analysts think that it could deliver not-so-boring growth. 
Via The Motley Fool
News headline image
Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys ↗
And their yields are both over 3%. 
Via The Motley Fool
News headline image
3 Things About Pfizer That Smart Investors Know ↗
They're all about the future. 
Via The Motley Fool
News headline image
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug? ↗
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday. 
Via Investor's Business Daily
News headline image
3 Top Biotech Stocks to Buy in August ↗
Each of these companies makes for a great vehicle to play an aging demographic. 
Via The Motley Fool
News headline image
Analysts Love This Newly Formed Healthcare Company; Should You? ↗
Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target. 
Via The Motley Fool
News headline image
Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript ↗
VTRS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
How This Historic FDA Approval Benefits Viatris ↗
Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former. 
Via The Motley Fool
News headline image
Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection ↗
The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high... 
Via Benzinga
News headline image
Earnings Scheduled For August 9, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
How To Find Value Stocks July 2021 ↗
Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value. 
Via Talk Markets
News headline image
10 Worst Performing S&P 500 Stocks Of 2021 ↗
The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in... 
Via Benzinga
Topics Stocks
News headline image
Why Viatris Stock Rocketed Higher in May ↗
This undervalued dividend stock finally found its footing in May. 
Via The Motley Fool
News headline image
2 Best Value Stocks to Buy Now ↗
Looking for solid companies trading on the cheap? Here are your top bets! 
Via The Motley Fool
News headline image
2 Healthcare Stocks That Could Be Millionaire-Makers ↗
The combination of stability and innovation makes these giants safe bets for long-term returns. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Is Viatris a Good Stock to Buy for 2021? ↗
Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios. 
Via The Motley Fool
News headline image
Why Is No One Talking About Viatris Stock? ↗
This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story